recombinant human basic fibroblast growth factor Search Results


95
MedChemExpress fgf2 recombinant protein
Fgf2 Recombinant Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+basic+fibroblast+growth+factor/Recombinant+Human+Basic+Fibroblast+Growth+Factor/pm38815785-62-16-22
Average 95 stars, based on 1 article reviews
fgf2 recombinant protein - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
Proteintech recombinant human fgf basic ts
Recombinant Human Fgf Basic Ts, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+basic+fibroblast+growth+factor/Animal-free+Recombinant+Human+FGF+Basic-TS/pmc07780036-37-18-23
Average 93 stars, based on 1 article reviews
recombinant human fgf basic ts - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Aviva Systems recombinant human basic fibroblast growth factor
Recombinant Human Basic Fibroblast Growth Factor, supplied by Aviva Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+basic+fibroblast+growth+factor/Recombinant+human+Fibroblast+growth+factor+5+protein+(OPCA00823)/pm35022635-42-0-9
Average 90 stars, based on 1 article reviews
recombinant human basic fibroblast growth factor - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
Proteintech kgf
<t>KGF</t> Mediated its Effects on HIOECs through Erk1/2 and Akt Signaling. (A and B) Western blot detection of the expression level of KGFR in HIOECs after KGF treatment, (C and D) the phosphorylation level of Jak2 and Stat3 after KGF stimulation for 15 min, and (E and F) the phosphorylation level of Erk1/2, p38, Jnk, and Akt after KGF stimulation for 15 min. n=3 independent experiments. Analysis of matrix protein expression in protein extracts from each group by ImageJ. (G) EdU labeling assay: the impact of U0126 and Ly294002 on the proliferation ability of HIOECs. (H) The quantification shown in the right graph indicates the mean ± SEM. <t>(I)</t> <t>MTT</t> assay: the impact of U0126 and Ly294002 on the proliferation ability of HIOECs. Data are expressed as the means ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.
Kgf, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+basic+fibroblast+growth+factor/Animal-free+Recombinant+Human+FGF-7/bio_rxiv__508416-116-14-17
Average 93 stars, based on 1 article reviews
kgf - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Alomone Labs n m recombinant basic fibroblast growth factor
<t>KGF</t> Mediated its Effects on HIOECs through Erk1/2 and Akt Signaling. (A and B) Western blot detection of the expression level of KGFR in HIOECs after KGF treatment, (C and D) the phosphorylation level of Jak2 and Stat3 after KGF stimulation for 15 min, and (E and F) the phosphorylation level of Erk1/2, p38, Jnk, and Akt after KGF stimulation for 15 min. n=3 independent experiments. Analysis of matrix protein expression in protein extracts from each group by ImageJ. (G) EdU labeling assay: the impact of U0126 and Ly294002 on the proliferation ability of HIOECs. (H) The quantification shown in the right graph indicates the mean ± SEM. <t>(I)</t> <t>MTT</t> assay: the impact of U0126 and Ly294002 on the proliferation ability of HIOECs. Data are expressed as the means ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.
N M Recombinant Basic Fibroblast Growth Factor, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+basic+fibroblast+growth+factor/Recombinant+human+FGF-b+protein/pmc05132010-76-53-61
Average 94 stars, based on 1 article reviews
n m recombinant basic fibroblast growth factor - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Proteintech growth factor β tgf β recombinant protein 112
<t>KGF</t> Mediated its Effects on HIOECs through Erk1/2 and Akt Signaling. (A and B) Western blot detection of the expression level of KGFR in HIOECs after KGF treatment, (C and D) the phosphorylation level of Jak2 and Stat3 after KGF stimulation for 15 min, and (E and F) the phosphorylation level of Erk1/2, p38, Jnk, and Akt after KGF stimulation for 15 min. n=3 independent experiments. Analysis of matrix protein expression in protein extracts from each group by ImageJ. (G) EdU labeling assay: the impact of U0126 and Ly294002 on the proliferation ability of HIOECs. (H) The quantification shown in the right graph indicates the mean ± SEM. <t>(I)</t> <t>MTT</t> assay: the impact of U0126 and Ly294002 on the proliferation ability of HIOECs. Data are expressed as the means ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.
Growth Factor β Tgf β Recombinant Protein 112, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+basic+fibroblast+growth+factor/Animal-free+Recombinant+Human+FGF-4/10__1016_slash_j__jpha__2026__101610-84-2-11
Average 94 stars, based on 1 article reviews
growth factor β tgf β recombinant protein 112 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
RayBiotech inc recombinant human basic fibroblast growth factor bfgf
Figure 3. Basic <t>fibroblast</t> growth factor <t>(bFGF)</t> reduced the increase in endothelial monolayer permeability and apoptosis induced by oxygen-glucose deprivation/reperfusion (OGD/R). (A) Treatment with bFGF significantly decreased the permeability of HBMECs 12 h after OGD/R treatment. (B) Quantification and (C) immunostaining of apoptotic cells 12 h post-OGD/R, as detected by the TUNEL assay. The number of immunoreactive cells was reduced by bFGF, indicating that it suppressed OGD/ R-induced HBMEC apoptosis. The control or bFGF group vs. the OGD/R group (** P<0.01). Inhibition of FGFR1 with PD173074 or inhibition of ERK with PD98059 compared with the bFGF group (## P<0.01). N=6 in each group. N=3 independent experiments.
Recombinant Human Basic Fibroblast Growth Factor Bfgf, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+basic+fibroblast+growth+factor/Fibroblast+Growth+Factor-Basic%2C+Human+Recombinant/10__12659_slash_msm__918626-44-0-10
Average 93 stars, based on 1 article reviews
recombinant human basic fibroblast growth factor bfgf - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Creative BioMart human fgfr1
Figure 3. Basic <t>fibroblast</t> growth factor <t>(bFGF)</t> reduced the increase in endothelial monolayer permeability and apoptosis induced by oxygen-glucose deprivation/reperfusion (OGD/R). (A) Treatment with bFGF significantly decreased the permeability of HBMECs 12 h after OGD/R treatment. (B) Quantification and (C) immunostaining of apoptotic cells 12 h post-OGD/R, as detected by the TUNEL assay. The number of immunoreactive cells was reduced by bFGF, indicating that it suppressed OGD/ R-induced HBMEC apoptosis. The control or bFGF group vs. the OGD/R group (** P<0.01). Inhibition of FGFR1 with PD173074 or inhibition of ERK with PD98059 compared with the bFGF group (## P<0.01). N=6 in each group. N=3 independent experiments.
Human Fgfr1, supplied by Creative BioMart, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+basic+fibroblast+growth+factor/Recombinant+Human+Fibroblast+Growth+Factor+Receptor+1%2C+His-tagged/pm25388665-53-20-23
Average 90 stars, based on 1 article reviews
human fgfr1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
Proteintech hfgf
Figure 3. Basic <t>fibroblast</t> growth factor <t>(bFGF)</t> reduced the increase in endothelial monolayer permeability and apoptosis induced by oxygen-glucose deprivation/reperfusion (OGD/R). (A) Treatment with bFGF significantly decreased the permeability of HBMECs 12 h after OGD/R treatment. (B) Quantification and (C) immunostaining of apoptotic cells 12 h post-OGD/R, as detected by the TUNEL assay. The number of immunoreactive cells was reduced by bFGF, indicating that it suppressed OGD/ R-induced HBMEC apoptosis. The control or bFGF group vs. the OGD/R group (** P<0.01). Inhibition of FGFR1 with PD173074 or inhibition of ERK with PD98059 compared with the bFGF group (## P<0.01). N=6 in each group. N=3 independent experiments.
Hfgf, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+basic+fibroblast+growth+factor/Animal-free+Recombinant+Human+FGF-8b/pmc10469866-120-64-65
Average 94 stars, based on 1 article reviews
hfgf - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

91
Beijing Solarbio Science recombinant human fibroblast growth factor basic b fgf
Figure 3. Basic <t>fibroblast</t> growth factor <t>(bFGF)</t> reduced the increase in endothelial monolayer permeability and apoptosis induced by oxygen-glucose deprivation/reperfusion (OGD/R). (A) Treatment with bFGF significantly decreased the permeability of HBMECs 12 h after OGD/R treatment. (B) Quantification and (C) immunostaining of apoptotic cells 12 h post-OGD/R, as detected by the TUNEL assay. The number of immunoreactive cells was reduced by bFGF, indicating that it suppressed OGD/ R-induced HBMEC apoptosis. The control or bFGF group vs. the OGD/R group (** P<0.01). Inhibition of FGFR1 with PD173074 or inhibition of ERK with PD98059 compared with the bFGF group (## P<0.01). N=6 in each group. N=3 independent experiments.
Recombinant Human Fibroblast Growth Factor Basic B Fgf, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+basic+fibroblast+growth+factor/Recombinant+Human+Fibroblast+Growth+Factor+4%2FFGF-4/pm29039459-52-54-75
Average 91 stars, based on 1 article reviews
recombinant human fibroblast growth factor basic b fgf - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

90
Aviva Systems human fgf23 elisa
Figure 3. Basic <t>fibroblast</t> growth factor <t>(bFGF)</t> reduced the increase in endothelial monolayer permeability and apoptosis induced by oxygen-glucose deprivation/reperfusion (OGD/R). (A) Treatment with bFGF significantly decreased the permeability of HBMECs 12 h after OGD/R treatment. (B) Quantification and (C) immunostaining of apoptotic cells 12 h post-OGD/R, as detected by the TUNEL assay. The number of immunoreactive cells was reduced by bFGF, indicating that it suppressed OGD/ R-induced HBMEC apoptosis. The control or bFGF group vs. the OGD/R group (** P<0.01). Inhibition of FGFR1 with PD173074 or inhibition of ERK with PD98059 compared with the bFGF group (## P<0.01). N=6 in each group. N=3 independent experiments.
Human Fgf23 Elisa, supplied by Aviva Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+basic+fibroblast+growth+factor/FGF23+Human+-+Recombinant+Human+Fibroblast+Growth+Factor-23/pm36926938-50-7-10
Average 90 stars, based on 1 article reviews
human fgf23 elisa - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
MedChemExpress recombinant fgf1
Figure 3. Basic <t>fibroblast</t> growth factor <t>(bFGF)</t> reduced the increase in endothelial monolayer permeability and apoptosis induced by oxygen-glucose deprivation/reperfusion (OGD/R). (A) Treatment with bFGF significantly decreased the permeability of HBMECs 12 h after OGD/R treatment. (B) Quantification and (C) immunostaining of apoptotic cells 12 h post-OGD/R, as detected by the TUNEL assay. The number of immunoreactive cells was reduced by bFGF, indicating that it suppressed OGD/ R-induced HBMEC apoptosis. The control or bFGF group vs. the OGD/R group (** P<0.01). Inhibition of FGFR1 with PD173074 or inhibition of ERK with PD98059 compared with the bFGF group (## P<0.01). N=6 in each group. N=3 independent experiments.
Recombinant Fgf1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+basic+fibroblast+growth+factor/Recombinant+Human+Acidic+Fibroblast+Growth+Factor/bio_rxiv__2025__10__01__679897-212-21-35
Average 93 stars, based on 1 article reviews
recombinant fgf1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


KGF Mediated its Effects on HIOECs through Erk1/2 and Akt Signaling. (A and B) Western blot detection of the expression level of KGFR in HIOECs after KGF treatment, (C and D) the phosphorylation level of Jak2 and Stat3 after KGF stimulation for 15 min, and (E and F) the phosphorylation level of Erk1/2, p38, Jnk, and Akt after KGF stimulation for 15 min. n=3 independent experiments. Analysis of matrix protein expression in protein extracts from each group by ImageJ. (G) EdU labeling assay: the impact of U0126 and Ly294002 on the proliferation ability of HIOECs. (H) The quantification shown in the right graph indicates the mean ± SEM. (I) MTT assay: the impact of U0126 and Ly294002 on the proliferation ability of HIOECs. Data are expressed as the means ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.

Journal: bioRxiv

Article Title: KGF induces podosome formation via integrin-Erk1/2 signaling in human immortalized oral epithelial cells

doi: 10.1101/508416

Figure Lengend Snippet: KGF Mediated its Effects on HIOECs through Erk1/2 and Akt Signaling. (A and B) Western blot detection of the expression level of KGFR in HIOECs after KGF treatment, (C and D) the phosphorylation level of Jak2 and Stat3 after KGF stimulation for 15 min, and (E and F) the phosphorylation level of Erk1/2, p38, Jnk, and Akt after KGF stimulation for 15 min. n=3 independent experiments. Analysis of matrix protein expression in protein extracts from each group by ImageJ. (G) EdU labeling assay: the impact of U0126 and Ly294002 on the proliferation ability of HIOECs. (H) The quantification shown in the right graph indicates the mean ± SEM. (I) MTT assay: the impact of U0126 and Ly294002 on the proliferation ability of HIOECs. Data are expressed as the means ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.

Article Snippet: HIOECs at 3x10 4 cells/well were seeded in the 96-well plate and exposed to KGF (10 ng/mL; Proteintech) for 24 h. For MTT assays, the cells were incubated with 20 μL of MTT solution (5 mg/mL) at 37°C for 4 h. The supernatant was discarded, and 150 μL of dimethyl sulfoxide (DMSO) was added to each well.

Techniques: Western Blot, Expressing, Phospho-proteomics, Labeling, MTT Assay

Figure 3. Basic fibroblast growth factor (bFGF) reduced the increase in endothelial monolayer permeability and apoptosis induced by oxygen-glucose deprivation/reperfusion (OGD/R). (A) Treatment with bFGF significantly decreased the permeability of HBMECs 12 h after OGD/R treatment. (B) Quantification and (C) immunostaining of apoptotic cells 12 h post-OGD/R, as detected by the TUNEL assay. The number of immunoreactive cells was reduced by bFGF, indicating that it suppressed OGD/ R-induced HBMEC apoptosis. The control or bFGF group vs. the OGD/R group (** P<0.01). Inhibition of FGFR1 with PD173074 or inhibition of ERK with PD98059 compared with the bFGF group (## P<0.01). N=6 in each group. N=3 independent experiments.

Journal: Medical Science Monitor

Article Title: Basic Fibroblast Growth Factor Reduces Permeability and Apoptosis of Human Brain Microvascular Endothelial Cells in Response to Oxygen and Glucose Deprivation Followed by Reoxygenation via the Fibroblast Growth Factor Receptor 1 (FGFR1)/ERK Pathway

doi: 10.12659/msm.918626

Figure Lengend Snippet: Figure 3. Basic fibroblast growth factor (bFGF) reduced the increase in endothelial monolayer permeability and apoptosis induced by oxygen-glucose deprivation/reperfusion (OGD/R). (A) Treatment with bFGF significantly decreased the permeability of HBMECs 12 h after OGD/R treatment. (B) Quantification and (C) immunostaining of apoptotic cells 12 h post-OGD/R, as detected by the TUNEL assay. The number of immunoreactive cells was reduced by bFGF, indicating that it suppressed OGD/ R-induced HBMEC apoptosis. The control or bFGF group vs. the OGD/R group (** P<0.01). Inhibition of FGFR1 with PD173074 or inhibition of ERK with PD98059 compared with the bFGF group (## P<0.01). N=6 in each group. N=3 independent experiments.

Article Snippet: Recombinant human basic fibroblast growth factor (bFGF) was purchased from RayBiotech (Atlanta, GA, USA).

Techniques: Permeability, Immunostaining, TUNEL Assay, Control, Inhibition

Figure 4. Following oxygen-glucose deprivation/reperfusion (OGD/R) of endothelial cells, basic fibroblast growth factor (bFGF) inhibited the decrease in tight junction and adherens junction proteins. (A–D) Treatment with bFGF reversed or reduced zonula occludens-1 (ZO-1), occludin, claudin-5, and b-catenin expression in HBMECs 24 h after OGD/R treatment. Inhibition of fibroblast growth factor receptor 1 (FGFR1) with PD173074 and inhibition of ERK with PD98059 reversed the protective effect of bFGF.

Journal: Medical Science Monitor

Article Title: Basic Fibroblast Growth Factor Reduces Permeability and Apoptosis of Human Brain Microvascular Endothelial Cells in Response to Oxygen and Glucose Deprivation Followed by Reoxygenation via the Fibroblast Growth Factor Receptor 1 (FGFR1)/ERK Pathway

doi: 10.12659/msm.918626

Figure Lengend Snippet: Figure 4. Following oxygen-glucose deprivation/reperfusion (OGD/R) of endothelial cells, basic fibroblast growth factor (bFGF) inhibited the decrease in tight junction and adherens junction proteins. (A–D) Treatment with bFGF reversed or reduced zonula occludens-1 (ZO-1), occludin, claudin-5, and b-catenin expression in HBMECs 24 h after OGD/R treatment. Inhibition of fibroblast growth factor receptor 1 (FGFR1) with PD173074 and inhibition of ERK with PD98059 reversed the protective effect of bFGF.

Article Snippet: Recombinant human basic fibroblast growth factor (bFGF) was purchased from RayBiotech (Atlanta, GA, USA).

Techniques: Expressing, Inhibition